Decellularized bovine corneal posterior lamellae as carrier matrix for cultivated human corneal endothelial cells

Current Eye Research

Volumn 37, Issue 3, 2012, Pages 179-186

  Bayyoud, Tarek ^a   Thaler, Sebastian ^a   Hofmann, Johanna ^a   Maurus, Christine ^a   Spitzer, Martin Stephan ^a   Bartz Schmidt, Karl Ulrich ^a   Szurman, Peter ^a   Yoeruek, Efdal ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Corneal tissue engineering; Decellularized carrier matrix; Endothelial disease; Human corneal endothelial cells; Xenotransplantation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); COLLAGEN TYPE 4; COLLAGEN TYPE 8; CONNEXIN 43; CYTOKERATIN 3; PROTEIN ZO1;

ANIMAL CELL; ARTICLE; CELL DENSITY; CELL EXPANSION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CORNEA; CORNEA CELL; CORNEA TRANSPLANTATION; DECELLULARIZED BOVINE CORNEA; DESCEMET MEMBRANE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAMELLAR BODY; NONHUMAN; PRIORITY JOURNAL;

AGED; ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; CATTLE; CELL COUNT; CELL CULTURE TECHNIQUES; CONNEXIN 43; CORNEA; ENDOTHELIUM, CORNEAL; EXTRACELLULAR MATRIX PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MEMBRANE PROTEINS; PHENOTYPE; PHOSPHOPROTEINS; SODIUM-BICARBONATE SYMPORTERS; SODIUM-POTASSIUM-EXCHANGING ATPASE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84857391639     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.644382     Document Type: Article

References (34)

1. Waring GO 3rd, Bourne WM, Edelhauser HF, Kenyon KR. The corneal endothelium. Normal and pathologic structure and function. Ophthalmology. 1982;89:531-590.
2. Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Akagi Y. Corneal changes after small-incision cataract surgery in patients with diabetes mellitus. Arch Ophthalmol. 2004;122: 966-969.
3. Kaufman HE, Katz JI. Pathology of the corneal endothelium. Invest Ophthalmol Vis Sci. 1977;16:265-268.
4. Darlington JK, Adrean SD, Schwab IR. Trends of penetrating keratoplasty in the United States from 1980 to 2004. Ophthalmology. 2006;113:2171-2175.
5. Dorrepaal SJ, Cao KY, Slomovic AR. Indications for penetrating keratoplasty in a tertiary referral centre in Canada, 1996-2004. Can J Ophthalmol. 2007;42:244-250.
6. Chen ES, Terry MA, Shamie N, Hoar KL, Friend DJ. Descemet-stripping automated endothelial keratoplasty: six-month results in a prospective study of 100 eyes. Cornea. 2008;27:514-520.
7. Melles GR, Ong TS, Ververs B, van der Wees J. Descemet membrane endothelial keratoplasty (DMEK). Cornea. 2006;25:987-990.
8. Melles GR. Posterior lamellar keratoplasty: DLEK to DSEK to DMEK. Cornea. 2006;25:879-881.
9. Muraine M, Toubeau D, Menguy E, Brasseur G. Analysing the various obstacles to cornea postmortem procurement. Br J Ophthalmol. 2002;86:864-868.
10. Reinhard T, Böhringer D, Bogen A, Sundmacher R. The transplantation law: A chance to overcome the shortage of corneal grafts in germany? Transplant Proc. 2002;34:1322-1324.
11. Golchet G, Carr J, Harris MG. Why don't we have enough cornea donors? A literature review and survey. Optometry. 2000;71:318-328.
12. Joyce NC, Zhu CC. Human corneal endothelial cell proliferation: potential for use in regenerative medicine. Cornea. 2004;23:S8-S19.
13. Shimmura S, Miyashita H, Konomi K et al. Transplantation of corneal endothelium with Descemet's membrane using a hyroxyethyl methacrylate polymer as a carrier. Br J Ophthalmol. 2005;89:134-137.
14. Mimura T, Yamagami S, Yokoo S et al. Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model. Invest Ophthalmol Vis Sci. 2004;45: 2992-2997.
15. Lai JY, Chen KH, Hsu WM, Hsiue GH, Lee YH. Bioengineered human corneal endothelium for transplantation. Arch Ophthalmol. 2006;124:1441-1448.
16. Wencan W, Mao Y, Wentao Y et al. Using basement membrane of human amniotic membrane as a cell carrier for cultivated cat corneal endothelial cell transplantation. Curr Eye Res. 2007;32:199-215.
17. Mirsadraee S, Wilcox HE, Watterson KG et al. Biocompatibility of acellular human pericardium. J Surg Res. 2007;143: 407-414.
18. Mirsadraee S, Wilcox HE, Korossis SA et al. Development and characterization of an acellular human pericardial matrix for tissue engineering. Tissue Eng. 2006;12:763-773.
19. Oswal D, Korossis S, Mirsadraee S et al. Biomechanical characterization of decellularized and cross-linked bovine pericardium. J Heart Valve Dis. 2007;16:165-174.
20. Knight RL, Wilcox HE, Korossis SA, Fisher J, Ingham E. The use of acellular matrices for the tissue engineering of cardiac valves. Proc Inst Mech Eng H. 2008;222:129-143.
21. Grandi C, Baiguera S, Martorina F et al. Decellularized bovine reinforced vessels for small-diameter tissue-engineered vascular grafts. Int J Mol Med. 2011;28:315-325.
22. Ott HC, Matthiesen TS, Goh SK et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med. 2008;14:213-221.
23. Oh JY, Kim MK, Lee HJ, Ko JH, Wee WR, Lee JH. Processing porcine cornea for biomedical applications. Tissue Eng Part C Methods. 2009;15:635-645.
24. Zhou Y, Wu Z, Ge J et al. Development and characterization of acellular porcine corneal matrix using sodium dodecylsulfate. Cornea. 2011;30:73-82.
25. Du L, Wu X, Pang K, Yang Y. Histological evaluation and biomechanical characterisation of an acellular porcine cornea scaffold. Br J Ophthalmol. 2011;95:410-414.
26. Joyce NC. Proliferative capacity of the corneal endothelium. Prog Retin Eye Res. 2003;22:359-389.
27. Alaminos M, Del Carmen Sánchez-Quevedo M, Muñoz-Avila JI et al. Construction of a complete rabbit cornea substitute using a fibrin-agarose scaffold. Invest Ophthalmol Vis Sci. 2006;47:3311-3317.
28. Vrana NE, Builles N, Justin V et al. Development of a reconstructed cornea from collagen-chondroitin sulfate foams and human cell cultures. Invest Ophthalmol Vis Sci. 2008;49:5325-5331.
29. Liu Y, Gan L, Carlsson DJ et al. A simple, cross-linked collagen tissue substitute for corneal implantation. Invest Ophthalmol Vis Sci. 2006;47:1869-1875.
30. Doillon CJ, Watsky MA, Hakim M et al. A collagen-based scaffold for a tissue engineered human cornea: physical and physiological properties. Int J Artif Organs. 2003;26: 764-773.
31. Amano S, Shimomura N, Kaji Y, Ishii K, Yamagami S, Araie M. Antigenicity of porcine cornea as xenograft. Curr Eye Res. 2003;26:313-318.
32. Sasaki S, Funamoto S, Hashimoto Y et al. In vivo. Evaluation of a novel scaffold for artificial corneas prepared by using ultrahigh hydrostatic pressure to decellularize porcine corneas. Mol Vis. 2009;15:2022-2028.
33. Ponce Má,rquez S, Martínez VS, McIntosh Ambrose W et al. Decellularization of bovine corneas for tissue engineering applications. Acta Biomater. 2009;5:1839-1847.
34. Amano S, Shimomura N, Yokoo S, Araki-Sasaki K, Yamagami S. Decellularizing corneal stroma using N2 gas. Mol Vis. 2008;14:878-882.